PCORI has released two new funding opportunities under their traditional timeline.

Observational Analyses of Second-Line Pharmacological Agents in Type 2 Diabetes
Letter of Intent Deadline: June 2; Application Deadline: September 1 

Conducting Rare Disease Research using PCORnet®
Letter of Intent Deadline: June 2; Application Deadline: September 1
Limited to current awardees of PCORnet.

Also announced today were regularly scheduled RFP releases

Implementation of Effective Shared Decision Making Approaches in Practice Settings
Letter of Intent Deadline: June 18; Application Deadline: August 31

Limited Competition PFA: Implementation of PCORI-Funded Patient-Centered Outcomes Research Results
Letter of Intent Deadline: June 18; Application Deadline: August 31

A summary of the funding is available here.